Alignment Healthcare (ALHC) to Release Earnings on Thursday

Alignment Healthcare (NASDAQ:ALHC) is expected to be posting its Q1 2025 quarterly earnings results after the market closes on Thursday, May 1st. Analysts expect Alignment Healthcare to post earnings of ($0.14) per share and revenue of $889.83 million for the quarter.

Alignment Healthcare Stock Down 1.5 %

ALHC stock opened at $17.43 on Wednesday. The firm has a market cap of $3.34 billion, a PE ratio of -22.64 and a beta of 1.32. Alignment Healthcare has a 12 month low of $5.02 and a 12 month high of $21.06. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60. The firm has a 50 day simple moving average of $17.07 and a 200 day simple moving average of $14.18.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. Piper Sandler lifted their target price on Alignment Healthcare from $14.00 to $21.00 and gave the company an “overweight” rating in a research note on Tuesday, March 4th. Stifel Nicolaus raised their price target on Alignment Healthcare from $18.00 to $23.00 and gave the stock a “buy” rating in a research note on Tuesday, April 8th. Bank of America raised their price target on shares of Alignment Healthcare from $15.50 to $18.50 and gave the company a “buy” rating in a report on Tuesday, March 4th. Barclays upped their price target on Alignment Healthcare from $8.00 to $9.00 and gave the stock an “underweight” rating in a research note on Friday, February 28th. Finally, William Blair reissued an “outperform” rating on shares of Alignment Healthcare in a research report on Friday, February 28th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $16.61.

Insider Transactions at Alignment Healthcare

In other Alignment Healthcare news, CEO John E. Kao sold 90,000 shares of Alignment Healthcare stock in a transaction on Monday, April 14th. The stock was sold at an average price of $19.10, for a total value of $1,719,000.00. Following the completion of the transaction, the chief executive officer now owns 2,003,100 shares in the company, valued at approximately $38,259,210. The trade was a 4.30 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, President Dawn Christine Maroney sold 30,000 shares of the stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $13.72, for a total value of $411,600.00. Following the sale, the president now owns 1,576,097 shares in the company, valued at $21,624,050.84. The trade was a 1.87 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 2,156,855 shares of company stock valued at $34,744,307. Company insiders own 6.60% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.